Chiesi presents at the International Congress of the European Respiratory Society (ERS) 2022, which is being held in Barcelona until September 6, a new treatment for adults with chronic obstructive pulmonary disease (COPD) who are not adequately controlled with existing alternatives . “The innovation aims to alleviate the difficulties of the disease in the daily life of patients”, they point out from the company. It is an inhalation device for triple extrafine fixed therapy (beclomethasone dipropionate, dehydrated formoterol fumarate and glycopyrronium) through the NEXThaler dry powder inhaler (DPI). A treatment that will not only be available in DPI, but also in pressurized metered dose inhaler (pMDI). In this way you can choose the alternative that best suits the needs of each patient. “We are very proud to be able to offer an effective and comfortable alternative and increase the range of therapeutic options for COPD patients.” Says Alessandro Chiesi, commercial director of the international pharmaceutical group. To improve patient usability, the NEXThaler is equipped with an inhalation counter and feedback system that indicates dose delivery only if it is delivered and inhaled correctly. It requires a minimum inspiratory flow of 35 L/min to deliver the optimal drug dose. “People with chronic respiratory diseases deserve to lead a life that is not totally affected by their disease. Patients know the physical and emotional burden of their illnesses, which is why they are the most appropriate to propose and evaluate the situations they face every day”, adds Chiesi. Fight COPD People with this inflammatory lung disease, in addition to symptoms such as breathlessness or chronic cough, also experience frequent respiratory infections, weight loss, fatigue and inability to perform daily activities. This respiratory pathology is one of the main causes of death every year in Europe and it is estimated that it affects 5-10% of the adult population over 40 years of age. Several studies indicate that climate change negatively affects lung health. In fact, deaths from chronic conditions, such as COPD and asthma, increase during heat waves. Due to this and the gradual aging of the population, the incidence of COPD is expected to increase in the coming years. You might also be interested…